The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations.
Background: The hepatitis C virus (HCV) affects approximately 214,000 Canadians. While the availability of safe, effective direct-acting antivirals (DAA) has led to decreased rates of chronic HCV infection and increased treatment uptake, major challenges to achieving HCV elimination remain. This rep...
| Published in: | Canadian Liver Journal Vol. 8; no. 4; pp. 540 - 554 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Published: |
University of Toronto Press
Nov2025
|
| Online Access: | View this record in EBSCOhost |